Company Filing History:
Years Active: 2012-2013
Title: Jim Huber: Innovator in Cancer Treatment
Introduction
Jim Huber is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative work on antibodies. With a total of 2 patents to his name, Huber's inventions focus on inhibiting tumor growth.
Latest Patents
Huber's latest patents include "Antibodies against PDGFRα to inhibit tumor growth." This invention provides antibodies that bind to human PDGFRα and neutralize the activation of the receptor. The invention further outlines methods for neutralizing the activation of PDGFRα and methods of treating a mammal with a neoplastic disease using the antibodies alone or in combination with other agents. Another patent, "Antibodies against PDGFRα," shares similar objectives and methodologies, emphasizing the importance of these antibodies in cancer treatment.
Career Highlights
Throughout his career, Jim Huber has worked with prominent organizations such as Imclone LLC and the University of Washington. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Some of Huber's notable coworkers include Nick Loizos and Alessandro Fatatis. Their collaboration has likely contributed to the advancement of research and development in cancer therapies.
Conclusion
Jim Huber's work in developing antibodies for cancer treatment showcases his dedication to innovation in the medical field. His patents represent significant advancements that could potentially improve treatment options for patients with neoplastic diseases.